Resources

In this Exclusive Interview transcript, Dr. Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting about the treatment of obesity in people with either type 1 or type 2 diabetes, as well as the need for more aggressive prediabetes treatment.

In this Exclusive Interview, Dr. Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about the treatment of obesity in people with not just type 2 diabetes but type 1 as well, and the need for more aggressive prediabetes treatment.

In part 1 of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his work with diabetes patients and the growing epidemic of overweight and obesity among patients with type 1 diabetes.

In part 2 of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about prediabetes intervention and options for prediabetes treatment outside of metformin.

In part 3 of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about potentially more aggressive treatment of prediabetes.

In part 4 of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his message for health care experts and the use of bariatric surgery in people with type 1 diabetes.

In part 5, the conclusion of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his anticipated visit to the ADA convention.

In part 7 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the endocrinology of aging and quality of life for people living longer with diabetes.

In this week's Homerun Slides, we conclude this series on the latest diabetes advances with a look at a new spin on bikes and diabetes apps.

The effect of dietary intervention alone for the management of NAFLD and NASH has been evaluated extensively over the past 2–3 decades. These studies can be divided into two main types: those that have focused on weight reduction only, and clinical trials that have assessed the role of a particular dietary composition on hepatic steatosis.